The NHS has launched a High Court claim for damages for abuse of a dominant position in relation to the supply of Gaviscon against Reckitt Benckiser with all 10 Strategic Health Authorities and 144 Primary Care Trusts in England behind Andrew Lansley as Secretary of State for Health who is leading the action.
Last year the OFT fined Reckitt Benckiser £10m over its supply of Gaviscon to the NHS for abusing its dominant market position in the supply of heartburn remedies by restricting competition. Reckitt withdrew cheaper alternatives as their patents had expired, therefore limiting the choice available to prescribing pharmacists.
Christopher Vajda QC and Philip Woolfe are representing the Department for Health.
Please click below for more information on: